Which of the four elements of the diamond model do you believe has the strongest influence on a firm’s fate when it competes in international markets? (Chapter 9.5) ***Please use the updated APA 7 style format** Please use the textbook linked below as the main reference Kennedy, R. (2020) Strategic Management. Virginia Tech Publishing. https://pressbooks.lib.vt.edu/strategicmanagement/chapter/9-5-drivers-of-success-and-failure-when-competing-in-international-markets/
Michael Porter`s Diamond Model (also known as the Theory of National Competitive Advantage of Industries) is a diamond-shaped framework that focuses on explaining why certain industries within a particular nation are competitive internationally, whereas others might not. And why is it that certain companies in certain countries are capable of consistent innovation, whereas others might not? Porter argues that any company`s ability to compete in the international arena is based mainly on an interrelated set of location advantages that certain industries in different nations possess, namely: firm strategy, structure and rivalry; factor conditions; demand conditions; and related and supporting industries. If these conditions are favorable, it forces domestic companies to continuously innovate and upgrade.
way is an exceptionally controlled enzymatic cycle, bringing about the stepwise development of FC [REF looked into by 11 tricarico 2015 16067-16084]. The recently shaped cell cholesterol is either straightforwardly utilized as a forerunner for metabolites (bile acids, steroids, water solvent nutrients, remembered for the layer) or changed over towards CE by acyl-Co An acyl transferase (ACAT) and either effluxed towards the plasma compartment or put away in lipid beads [REF 12 35 goedeke]. The put away CE inside lipid drops can be changed over into FC by chemical touchy lipase (HSL)[REF]. Since fitting cell cholesterol levels are basic for ordinary cell digestion, the guideline of intracellular cholesterol levels are firmly constrained by criticism systems that work at both transcriptional as well as post-transcriptional levels [REF goedeke 10.11]. Low cell cholesterol sets off the MVA-pathway to upregulate the actuation of the rate restricting catalysts i.a. 3-hydroxy-3methylgkutaryl (HMGCR) [REF] and receptor interceded exogenous take-up [REF]. High cell cholesterol levels actuate atomic chemical receptors that thusly trigger record of cholesterol efflux related qualities i.a. ABC carriers and repress HMGCR articulation [REF].
Besides, the MVA-pathway is most popular as an objective for Statins, a broad recommended drug that restrains the rate restricting step; HMGcoA reductase. Because of the HMGCOA reductase hindrance, cholesterol levels decline in patients that experience the ill effects of hypercholesterolemia.
3.2 EXOGENOUS CHOLESTEROL
The second hotspot for cell cholesterol is exogenous interceded take-up. Exogenous cholesterol got through dietary take-up cover around 30% of the complete cholesterol pool [REF Kapourchali 2016 13]. Almost half of the absolute dietary cholesterol is retained, the rest of discharged through excrement [REF Clearfield 2003 Crouse 1978; Sudhop 2009 14-16]. Lipid ingestion from the digestive tract is a complex practical cooperation along the entire stomach related track; gastric, gastrointestinal, biliary and pancreatic. So, solubilisation of dietary lipids begins in the duodenum and proximal jejunum parts of the digestive tract where bile corrosive micelles hydrolyse CE into FC and unsaturated fats (FA). Micelles ingest the FC and FA and work with transport to the enterocytes of the small digestion tracts were FA is combined into triacylglycerol to shape fatty oils. Exogenous FC is changed over into CE in the ER by ACAT [REF 17]. Because of the hydrophobic person of CE its vehicle all through the body is worked with by lipoproteins.
3.3 LIPOPROTEIN METABOLISM